| Title | Drug Products not Withdrawn from Sale for Reasons of Safety or Effectiveness: NASONEX (Mometasone Furoate) Nasal Spray, 0.05 Milligram/Spray (50 Microgram) |
| ToC Doc | NASONEX (Mometasone Furoate) Nasal Spray, 0.05 Milligram/Spray (50 Microgram) |
| Docket Number | 2022-07563 |
| Type | Notice |
| Subject | Drug Products not Withdrawn from Sale for Reasons of Safety or Effectiveness: NASONEX (Mometasone Furoate) Nasal Spray, 0.05 Milligram/Spray (50 Microgram) |
| Publication Date | 2022-04-08 |
| Last Updated Date | 2022-04-07 08:15:09 -0400 |
| Last Public Inspection | 2022-04-07 |
| Filed At | 2022-04-07T08:45:00.000-04:00 |
| 2022-07563_PI.pdf (98260 bytes) | |
| Download | TXT / HTML / JSON |
| Number of Pages | 3 |
| Filing Type | regular |
| Agencies | Food and Drug Administration |
You can find the raw source document below...